MS in the Media - 3 April 2020
28 March - 3 April 2020
These are links to recent news stories about multiple sclerosis that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Support for carers during the current situation
Informal and family carers need more support as they try to look after people while dealing with reduced help from health and care services warn the carer support charities. The story includes the experience of a couple affected by MS
Source: Daily Express
MS Trust link: A family talks about caring (written before the current situation)
Ozanimod approved for RRMS
Ozanimod (Zeposia), a drug for relapsing remitting MS that works in a similar way to Gilenya, has been approved for licensing by the European Medicines Agency (EMA).
Source: MS News Today
MS Trust link: Ozanimod (Zeposia)
MS in the Media
27 Nov 2020 - 00:00
- Depression affects multitasking in MS
- Benefits process in Scotland
- Cancer risks and multiple sclerosis
- Gut immune cells and relapses
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
